NEW YORK, Nov. 13 – Bioinformatics startup X-Mine said it has licensed its data-mining platform to BioCardia, a developer of technologies and products designed to improve cardiac care .
Under the terms of the deal, BioCardia, of South San Francisco, Calif., will also have early access to X-Mine’s future molecular pattern recognition and computational tools.
“BioCardia is excited about this agreement with X-Mine, because we believe that X-Mine has a world class team of experts and a state of the art platform which can provide us with a substantial competitive advantage,” BioCardia CEO Peter Altman, said in a statement released Monday.
X-Mine of Brisbane, Calif., markets X-Miner, a molecular pattern recognition software tool that provides users with insight into gene expression and proteomic data.
Financial terms of the deal were not disclosed.